BellRing Brands (NYSE:BRBR) Sees Unusually-High Trading Volume – Still a Buy?

Shares of BellRing Brands Inc. (NYSE:BRBR) saw strong trading volume on Thursday. 3,315,342 shares were traded during mid-day trading, a decline of 25% from the previous session’s volume of 4,405,617 shares. The stock last traded at $9.22 and had previously closed at $8.66.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on BRBR shares. JPMorgan Chase & Co. increased their target price on shares of BellRing Brands from $13.00 to $17.00 and gave the stock an “overweight” rating in a report on Tuesday, July 28th. UBS Group set a $9.50 price target on shares of BellRing Brands in a report on Thursday. Stephens reaffirmed an “overweight” rating and set a $20.00 price objective on shares of BellRing Brands in a research note on Thursday, July 9th. Zacks Research downgraded BellRing Brands from a “hold” rating to a “strong sell” rating in a research note on Wednesday. Finally, BNP Paribas Exane assumed coverage on BellRing Brands in a report on Friday, October 9th. They set an “outperform” rating and a $12.00 target price on the stock. Ten analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $18.70.

BellRing Brands Stock Up 4.6%

The firm has a market capitalization of $1.09 billion, a price-to-earnings ratio of 6.62, a price-to-earnings-growth ratio of 4.19 and a beta of 0.43. The business’s fifty day moving average is $9.42 and its 200 day moving average is $11.26.

BellRing Brands (NYSE:BRBR) last announced its earnings results on Tuesday, August 4th. The company reported $0.30 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.07). The company had revenue of $570.40 million during the quarter, compared to analyst estimates of $548.72 million. BellRing Brands had a negative return on equity of 33.04% and a net margin of 7.28%. BellRing Brands’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.55 earnings per share. Equities research analysts expect that BellRing Brands Inc. will post 1.03 EPS for the current year.

Institutional Trading of BellRing Brands

A number of institutional investors have recently modified their holdings of the company. Diamond Hill Capital Management LLC Investment Advisor acquired a new position in shares of BellRing Brands during the second quarter worth about $42,868,000. Amundi raised its position in BellRing Brands by 106.4% in the 1st quarter. Amundi now owns 2,255,734 shares of the company’s stock valued at $36,295,000 after buying an additional 1,162,996 shares during the last quarter. River Road Asset Management LLC bought a new stake in BellRing Brands in the 4th quarter valued at approximately $56,465,000. Assenagon Asset Management S.A. lifted its stake in BellRing Brands by 0.4% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,342,471 shares of the company’s stock valued at $21,600,000 after acquiring an additional 5,671 shares in the last quarter. Finally, Bank of America Corp DE lifted its stake in BellRing Brands by 25.0% in the 1st quarter. Bank of America Corp DE now owns 1,248,761 shares of the company’s stock valued at $20,093,000 after acquiring an additional 250,144 shares in the last quarter. 94.97% of the stock is currently owned by institutional investors.

BellRing Brands Company Profile

BellRing Brands, Inc is a consumer packaged goods company focused on convenient nutrition products. The company develops, markets and sells ready-to-drink protein shakes, protein powders, protein bars and other sports-nutrition products designed for consumers seeking portable sources of protein and nutrition.

BellRing’s principal brands include Premier Protein, which offers shakes, powders and bars, and Dymatize, a sports-nutrition brand known for protein powders and related nutritional products.